109
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Cyclodextrin Inclusion Complexes of the Central Analgesic Drug Nefopam

, , , , &
Pages 1123-1134 | Published online: 25 Sep 2008

REFERENCES

  • Chankvetadze B., Endresz D., Bergenthal D., Blaschke G. Enantioseparation of mianserine analogues using capillary electrophoresis with neutral and charged cyclodextrins buffer modifiers. 13C study of the chiral recognition mechanism. J. Chromatrogr. A. 1995; 717: 245–253
  • Chankvetadze B., Burjanadze N., Pintore G., Bergenthal D., Bergander G., Mülenbrock C., Breitkreuz J., Blaschke G. Separation of brompheniramine enantiomers by capillary electrophoresis and study of chiral recognition mechanisms of cyclodextrins using NMR-spectroscopy, UV spectrometry, electrospray ionization mass spectrometry and X-ray crystallography. J. Chromatogr. A. 2000; 878: 471–484, [CSA], [CROSSREF]
  • Correia I., Bezzenine N., Ronzani N., Platzer N., Beloeil J. C., Doan B. T. Study of inclusion complexes of acridine with β- and (2,6-di-o-methyl)-β-cyclodextrin by use of solubility diagrams and NMR spectroscopy. J. Phys. Org. Chem. 2002; 15: 647–659, [CSA], [CROSSREF]
  • De Vries M. E., Boddé H. E., Coos Verhoef J., Junginger H. E. Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 1991; 8: 271–303, [INFOTRIEVE], [CSA]
  • Ding W., Fritz J. S. Carbamate chiral surfactants for capillary electrophoresis. J. Chromatogr. A 1999; 831: 311–320, [CSA], [CROSSREF]
  • Djedaïni F., Lin S. Z., Perly B., Wouessidjewe D. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin: indometacin inclusion complex. J. Pharm. Sci. 1990; 79: 643–646, [CSA], [CROSSREF]
  • Dollo G., Le Corre P., Chevanne F., Le Verge R. Inclusion complexation of amide-typed local anaesthetics with β-cyclodextrin and its derivatives. I. Physicochemical characterization. Int. J. Pharm. 1996; 131: 219–228, [CSA], [CROSSREF]
  • Dotsikas Y., Kontopanou E., Allagiannis C., Loukas Y. L. Interaction of 6-p-toluidinylnaphtalene-2-sulphonate with β-cyclodextrin. J. Pharm. Biomed. Anal. 2000; 23: 997–1003, [INFOTRIEVE], [CSA], [CROSSREF]
  • Dodziuk H., Kozminski W., Lukin O., Sybilska D. NMR manifextations and molecular dynamics modelling of chiral recognition of α-pinene by α-cyclodextrins. J. Mol. Struct. 2000; 523: 205–212, [CSA], [CROSSREF]
  • Dodziuk H., Kozminski W., Ejchart A. NMR studies of chiral recognition by cyclodextrins. Chirality 2004; 90–105, [CSA], [CROSSREF]
  • Duchêne D., Wouessidjewe D. Pharmaceutical uses of cyclodextrines and derivatives. Drug. Dev. Ind. Pharm. 1990; 17: 2487–2499, [CSA]
  • Fanali S. Identification of chiral drug isomers by capillary electrophoresis. J. Chromatogr. A. 2000; 875: 89–122, [INFOTRIEVE], [CSA], [CROSSREF]
  • Faucci M. T., Melani F., Mura P. 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 2000; 23: 25–31, [INFOTRIEVE], [CSA], [CROSSREF]
  • Fernandes C. M., Vieira M. T., Veiga F. J. B. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 2001; 15: 79–88, [CSA], [CROSSREF]
  • Fernandes C. M., Carvalho R. A., Pereira da Costa S., Veiga F. J. B. Multimodal molecular encapsulation of nicardipine hydrochloride by β-cyclodextrin, hydroxypropyl-β-cyclodextrin and triacetyl-β-cyclodextrin. Structural studies by 1H NMR and ROESY experiments. Eur. J. Pharm. Sci. 2003; 18: 285–296, [INFOTRIEVE], [CSA], [CROSSREF]
  • Frömming K. H., Szejtli J. Cyclodextrin in Pharmacy. Informa UK Ltd, Dordrecht 1994
  • Ganza-Gonzales A., Vila-Jato J. L., Anguinao-Igea S., Otero-Espinar F. J., Blanco-Mendez J. A proton nuclear magnetic resonance study of the inclusion complex with β-cyclodextrin. Int. J. Pharm. 1994; 106: 179–185, [CSA], [CROSSREF]
  • Gosnat M., Djedaïni-Pilard F., Perly B. Etude par RMN de la reconnaissance chirale par des cyclodextrines modifiées. J. Chim. Phys. 1995; 92: 1777–1781, [CSA]
  • Harris D., Robinson J. R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992; 81: 1–10, [INFOTRIEVE], [CSA], [CROSSREF]
  • Heel R. C., Brogden R. N., Pakes G. E., Speight T. M., Avery G. S. Nefopam: a review of its pharmacological properties and therapeutic efficacity. Drugs 1980; 19: 249–267, [INFOTRIEVE], [CSA]
  • Heuermann H., Blaschke G. Simultaneous enantioselective determination and quantification of dimethindene and its metabolite N-demethyl-dimethindene in human urine using cyclodextrins as chiral additives in capillary electrophoresis. J. Pharm. Biomed. Anal. 1994; 12: 753–760, [INFOTRIEVE], [CSA], [CROSSREF]
  • Higuchi T., Connors K. A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 1965; 4: 117–212, [CSA]
  • Job P. Recherches sur la formation de complexes minéraux en solution et sur leur stabilité. Ann. Chem. 1928; 9: 113–114, [CSA]
  • Kim J. H., Lee S. K., Ki M. H., Choi W. K., Ahn S. K., Shin H. J., Hong C. I. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-(beta)-cyclodextrin. Int. J. Pharm. 2004; 272: 79–89, [INFOTRIEVE], [CSA], [CROSSREF]
  • Lai S., Locci E., Piras A., Porcedda S., Lai A., Marongiu B. Imazil-cyclomaltoheptaose (β-cyclodextrin) inclusion complex: preparation by supercritical carbon dioxide and 13C CPMAS and 1H NMR characterization. Carbohydr. Res. 2003; 338: 2227–2232, [INFOTRIEVE], [CSA], [CROSSREF]
  • Lin Y. H., Hwang J. L., Huang L. W., Chen H. J. Use of sublingual buprenorphine for pain relief in office hysteroscopy. J. Minim. Invasive Gynecol. 2005; 12: 347–350, [INFOTRIEVE], [CSA], [CROSSREF]
  • Loftsson T., Brewster M. E. Pharmaceutical applications of cyclodextrins. l. Drug solubilisation and stabilization. J. Pharm. Sci. 1996; 85: 1017–1025, [INFOTRIEVE], [CSA], [CROSSREF]
  • Loftsson T., Magnusdottir A., Masson M., Sigurjonsdottir J. F. Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 2002; 91: 2307–2316, [INFOTRIEVE], [CSA], [CROSSREF]
  • Loftsson T., Masson M., Sigurjonsdottir J. F. Methods to enhance the complexation efficiency of cyclodextrins. S.T.P. Pharma. Sci. 1999; 9: 237–242, [CSA]
  • Mannila J., Jarvinen T., Jarvinen K., Tarvainen M., Jarho P. Effects of RM-beta-CD on sublingual bioavailability of delta(9)-tetrahydrocannabinol in rabbits. Eur. J. Pharm. Sci. 2005; 26: 71–77, [INFOTRIEVE], [CSA], [CROSSREF]
  • Masson M., Loftsson T., Masson G., Stefanson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Release. 1999; 59: 107–118, [INFOTRIEVE], [CSA], [CROSSREF]
  • McLintock T. T. C., Kenny G. N. C., Howie J. C., McArdle C. S., Lawrie S., Aitken H. Assessment of the analgesic efficacity of nefopam hydrochloride after upper abdominal surgery: a study using patient controlled analgesia. Br. J. Surg. 1988; 75(8)779–781, [INFOTRIEVE], [CSA]
  • Mimoz O., Incagnoli P., Josse C., Gillon M. C., Kuhlman L., Soilleux H., Fletcher D. Analgesy efficacy and safety of nefopam vs. propacetamol following hepatic resection. Anaesthesia 2001; 56: 520–525, [INFOTRIEVE], [CSA], [CROSSREF]
  • Miro A., Quaglia F., Calignano A., Barbato F., Cappello B., La Rotonda M. I. Physicochemical and pharmacological properties of nimesulide/β-cyclodextrin formulations. S.T.P. Pharma. Sci. 2000; 10: 157–164, [CSA]
  • Pose-Vilarnovo B., Perdomo-Lopez I., Echezarreta-Lopez M., Schroth-Pardo P., Estrada E., Torres-Labandeira J. J. Improvement of water solubility of sulfamethizole through its complexation with β- and hydroxypropyl-β-cyclodextrin; Characterization of the interaction in solution and in solid state. Eur. J. Pharm. Sci. 2001; 13: 325–331, [INFOTRIEVE], [CSA], [CROSSREF]
  • Roselli C., Perly B., Duchêne D., Wouessidjewe D. β-Cyclodextrin and its derivatives as solubilizing fillers for tablet formulations: 1H-RMN contribution as the ultimate tool for the study of drug/cyclodextrin interaction. S.T.P. Pharma. Sci. 1999; 9: 267–271, [CSA]
  • Tenjarla S., Puranajoti P., Kasina R., Mandal T. Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. J. Pharm. Sci. 1998; 87: 425–429, [INFOTRIEVE], [CSA], [CROSSREF]
  • Veiga F., Teixeira-Dias J. J. C., Kedzierewicz F., Sousa A., Maincent P. Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Int. J. Pharm. 1996; 129: 63–71, [CSA], [CROSSREF]
  • Ventura C. A., Puglisi G., Zappala M., Mazzone G. A physico-chemical study on the interaction between papaverine and modified β-cyclodextrins. Int. J. Pharm. 1998; 160: 163–172, [CSA], [CROSSREF]
  • Vianna R. F. L., Bentley M. V. L. B., Ribeiro G., Carvalho F. S., Neto A. F., de Oliveira D. C. R., Collett J. H. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int. J. Pharm. 1998; 167: 205–213, [CSA], [CROSSREF]
  • Wang F., Khaledi M. G. Non-aqueous capillary electrophoresis chiral separations with sulphated β-cyclodextrin. J. Chromatogr. B. 1999; 731: 187–197, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.